Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02810080 · ClinicalTrials.gov registry record
FiO2 Closed Loop Control Ventilation
A clinical trial of Respiratory Failure and Wounds and Injuries, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT02810080: Completed study of Respiratory Failure and Wounds and Injuries, sponsored by Zoll Medical Corporation.
NCT02810080 is a study of Respiratory Failure and Wounds and Injuries that has completed, run by Zoll Medical Corporation. The registered enrollment target is 210 participants, below the 4,519-participant average among 40 other Respiratory Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02810080, a study of Respiratory Failure and Wounds and Injuries, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, multi-center trial involving critically-ill patients comparing conventional, manual control of inspired oxygen (FiO2) within a target range, with a computer-controlled, closed-loop FiO2 delivery using a continuous ventilator.
Primary Outcome
Relative duration is (time within SpO2 target of 92-96%)/12 hours where higher value demonstrates better ability of FiO2 control method to maintain appropriate oxygen saturation. Relative time the patient's SpO2 was maintained within target over the 12 hours on the study device, calculated as total time each patient had SpO2 within the 92 - 96% range divided by 12 hours with arcsin square root transformation
Conditions Studied
Interventions
- DEVICE Closed Loop Control Ventilation
- DEVICE Manual Control Ventilation
Study Locations (1)
Minnesota
- Regions Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-12 |
What the finished NCT02810080 record still lists
NCT02810080 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 4,519-participant average among 40 other Respiratory Failure trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Closed Loop Control Ventilation is the first listed.
NCT02810080 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02810080 about?
NCT02810080 is a clinical study titled "FiO2 Closed Loop Control Ventilation". A randomized, multi-center trial involving critically-ill patients comparing conventional, manual control of inspired oxygen (FiO2) within a target range, with a computer-controlled, closed-loop FiO2 delivery using a continuous ventilator.
What is the current status of trial NCT02810080?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2016-12. Estimated completion is 2020-12.
What conditions does trial NCT02810080 study?
This clinical trial studies the following conditions: Respiratory Failure, Wounds and Injuries.
What interventions are being tested in trial NCT02810080?
The interventions under investigation include: Closed Loop Control Ventilation (DEVICE), Manual Control Ventilation (DEVICE).
Who is sponsoring clinical trial NCT02810080?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02810080 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02810080's enrollment target sits among peer trials
210 15th of 40 higher than 26 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia